Biodesix, Inc.
BDSX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $21,768 | $20,018 | $17,958 | $20,429 |
| % Growth | 8.7% | 11.5% | -12.1% | – |
| Cost of Goods Sold | $4,106 | $4,031 | $3,703 | $4,342 |
| Gross Profit | $17,662 | $15,987 | $14,255 | $16,087 |
| % Margin | 81.1% | 79.9% | 79.4% | 78.7% |
| R&D Expenses | $2,992 | $3,269 | $2,870 | $2,414 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21,714 | $22,411 | $20,448 | $20,219 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7 | $26 | $73 | $103 |
| Operating Expenses | $24,713 | $25,706 | $23,391 | $22,736 |
| Operating Income | -$7,051 | -$9,719 | -$9,136 | -$6,649 |
| % Margin | -32.4% | -48.6% | -50.9% | -32.5% |
| Other Income/Exp. Net | -$1,665 | -$1,749 | -$1,965 | -$1,602 |
| Pre-Tax Income | -$8,716 | -$11,468 | -$11,101 | -$8,251 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,716 | -$11,468 | -$11,101 | -$8,251 |
| % Margin | -40% | -57.3% | -61.8% | -40.4% |
| EPS | -1.16 | -1.6 | -1.6 | -1.2 |
| % Growth | 27.5% | 0% | -33.3% | – |
| EPS Diluted | -1.16 | -1.6 | -1.6 | -1.2 |
| Weighted Avg Shares Out | 7,500 | 7,333 | 7,327 | 7,330 |
| Weighted Avg Shares Out Dil | 7,500 | 7,333 | 7,327 | 7,330 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,074 | $1,898 | $1,685 | $1,752 |
| Depreciation & Amortization | $1,407 | $1,412 | $1,405 | $1,398 |
| EBITDA | -$5,235 | -$8,158 | -$8,011 | -$5,101 |
| % Margin | -24% | -40.8% | -44.6% | -25% |